A novel recessive splicing mutation in the POU1F1 gene causing combined pituitary hormone deficiency
Y Carlomagno1, M Salerno, D Vivenza
1Laboratory of Human Genetics, Department of Medical Sciences, Eastern Piedmont University and Interdisciplinary Research Center on Autoimmune Diseases, 28100 Novara, Italy.
Insights
A novel POU1F1 gene mutation (IVS2-3insA) causes combined pituitary hormone deficiency (CPHD) in a homozygous patient. Heterozygous carriers may have reduced pituitary function, indicating incomplete compensation by a single normal allele.
Area of Science:
- Genetics
- Endocrinology
- Molecular Biology
Background:
- Combined pituitary hormone deficiency (CPHD) is often linked to mutations in the POU1F1 gene, which encodes a critical pituitary transcription factor.
- Understanding the genetic basis of CPHD is crucial for diagnosis and management.
Observation:
- A patient with severe growth failure and deficiencies in growth hormone (GH), prolactin (PRL), and thyroid-stimulating hormone (TSH) was investigated.
- The patient, born to consanguineous parents, was found to be homozygous for a novel POU1F1 mutation (IVS2-3insA).
Findings:
- The IVS2-3insA mutation leads to two aberrant mRNA splicing products: one with a deletion in exon 3 causing a premature stop codon, and another with complete exon 3 skipping.
- These splicing defects result in non-functional proteins, explaining the severe CPHD phenotype in the homozygous state.
- Heterozygous relatives carrying the mutation exhibited lower-than-normal PRL levels, suggesting that one normal POU1F1 allele may not fully compensate for pituitary function.
Implications:
- This study identifies a novel mutation in POU1F1 causing CPHD through aberrant splicing.
- The findings highlight that even in heterozygous carriers, a single functional POU1F1 allele may not be sufficient to maintain normal pituitary function, particularly for PRL secretion.
Background:
Mutations in the gene encoding the pituitary transcription factor POU1F1 (Pit-1, pituitary transcription factor-1) have been described in combined pituitary hormone deficiency (CPHD).
Aim:
The aim of this study was the characterisation of the molecular defect causing CPHD in a patient born to consanguineous parents.
Subject And Methods:
The case of a 12.5-yr-old girl presenting with severe growth failure at diagnosis (-3 SD score at 3 months) and deficiency of GH, PRL, and TSH was investigated for the presence of POU1F1 gene mutations by denaturing high performance liquid chromatography analysis.
Results:
A novel mutation adjacent to the IVS2 splicing acceptor site (IVS2-3insA) was identified in the patient at the homozygous state. Analysis of patient's lymphocyte mRNA and an in vitro splicing assay revealed the presence of 2 aberrant splicing products: a) deletion of the first 71 nucleotides of exon 3, altering the open reading frame and generating a premature stop codon, b) total exon 3 skipping resulting in an in frame deleted mRNA encoding a putative protein lacking part of the transactivation domain and of the POUspecific homeodomain. Notably, the patient's relatives heterozygous for the mutation had PRL levels under the normal range with no evident clinical symptoms.
Conclusions:
The IVS2- 3insAmutation, responsible for CPHD at the homozygous state, causes the presence of 2 aberrant splicing products encoding non-functional products. In the heterozygotes one normal allele might not guarantee a complete pituitary function.
Related Concept Videos
Pleiotropy
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
The Pituitary Gland
Cushing Syndrome II: Pathophysiology
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...


